首页|伏立诺他调控组蛋白去乙酰化酶-2促进软骨炎症修复的研究

伏立诺他调控组蛋白去乙酰化酶-2促进软骨炎症修复的研究

扫码查看
目的 探讨伏立诺他作为组蛋白去乙酰化酶(HDAC)抑制剂应用于促进软骨炎症修复作用及其机制.方法 首先进行大鼠体内实验,设置为对照组和退变组,造模成功后进行软骨取材,取大鼠软骨,进行切片行免疫组织化学HDAC-2染色,继而提取cDNA和蛋白质分别进行HDAC-2的基因、蛋白检测.然后于体外实验部分,体外分离培养大鼠软骨细胞,设置为对照组、白细胞介素-1组、白细胞介素-1+伏立诺他组,通过实时定量反转录聚合酶链反应(RT-qPCR)法检测HDAC-2、Ⅱ型胶原(Col2a1)、蛋白多糖(Acan)的基因表达,使用蛋白质印迹法(Western blot)检测乙酰化及总H3组蛋白表达,使用免疫荧光法标记HDAC-2蛋白.确定伏立诺他的效应后,最终使用大鼠退变模型,设置为退变组和退变+伏立诺他组,于注射7 d后进行取材,并做番红O染色及阿利新蓝染色.两组间比较行t检验.结果 退变组大鼠软骨的HDAC-2免疫组化蛋白分布高于对照组,其基因转录活性显著升高(0.96±0.05比1.34±0.12,t=5.83,P<0.01).体外实验部分,白细胞介素-1诱导HDAC-2的基因表达显著升高(0.87±0.11比1.88±0.64,t=3.12,P<0.05)且免疫荧光强度增加.伏立诺他处理后,软骨细胞的H3组蛋白乙酰化比例升高(对照组0.41±0.17比伏立诺他组1.09± 0.12,t=5.63,P<0.01).白细胞介素-1可抑制软骨细胞的Col2a1及Acan转录活性(4.86±0.64比2.28±0.49,t=5.53,P<0.01;2.72±0.75 比 1.29±0.31,t=3.06,P<0.05),而加入伏立诺他后,软骨细胞的 Co12a1 及 Acan 转录活性恢复(2.28±0.49 比 4.05±0.72,t=3.53,P<0.05;1.29± 0.31比2.58±0.58,t=3.38,P<0.05).后续体内实验设置退变组及退变+伏立诺他组,可见退变+伏立诺他组软骨的缺损、平整度、胶原纤维分布均优于退变组.结论 伏立诺他抑制HDAC-2活性,调控组蛋白去乙酰化,提高Ⅱ型胶原及蛋白多糖表达,促进骨炎症损伤修复.
Vorinostat promoted cartilage repair by the regulation of histone deacetylase-2
Objective To explore vorinostat,a histone deacetylase(HDAC)inhibitor,applied to promote cartilage repair and the underlying mechanisms.Methods Firstly,an in vivo experiment was conducted on rats,with a control group and a degeneration group.After successful modeling,cartilage samples were taken,and the rat cartilage was sliced for immunohistochemical HDAC-2 staining.Subse-quently,cDNA and protein were extracted for gene and protein detection of HDAC-2,respectively.Then,in the in vitro experiment section,rat chondrocytes were isolated and cultured in vitro,and set as control group,interleukin-1 group,and interleukin-1+vorinostat group.The gene expression of HDAC-2,type Ⅱcollagen(Col2a1),and proteoglycan(Acan)was detected by real-time quantitative reverse transcriptase-polymerase chain reaction(RT-qPCR),acetylation and total H3 histone protein expression were detected by Western blotting,and HDAC-2 protein was labeled by immunofluorescence.After determining the effect of vorinotat,a rat degeneration model was ultimately used,and a degeneration group and a degeneration+vorinotat group were set up.Samples were taken 7 days after injection and stained with safranin O and Ali-sin blue.The t-test was done for comparison between two groups.Results The distribution of HDAC-2 immunohistochemistry protein in the cartilage of the degenerative group rats was higher than that of the con-trol group,and its gene transcription activity was significantly increased(0.96±0.05 vs.1.34±0.12,t=5.83,P<0.01).In vitro experiments showed that interleukin-1 induced a significant increase in the gene expression of HDAC-2(0.87±0.11 vs.1.88±0.64,t=3.12,P<0.05)with increased immuno-fluorescence intensity.After treatment with vorinostat,the proportion of H3 histone acetylation in chondro-cytes increased(0.41±0.17 in the control group vs.1.09±0.12 in the vorinostat group,t=5.63,P<0.01).Interleukin-1 could inhibit the transcriptional activity of Col2a1 and Acan in chondrocytes(4.86± 0.64 vs.2.28±0.49,t=5.53,P<0.01;2.72±0.75 vs.1.29±0.31,t=3.06,P<0.05),while the addition of vorinostat restored the transcriptional activity of Col2a1 and Acan in chondrocytes(2.28± 0.49 vs.4.05±0.72,t=3.53,P<0.05;1.29±0.31 vs.2.58±0.58,t=3.38,P<0.05).Subse-quent in vivo experiments were conducted to set up the degenerative group and the degenerative+vorinostat group,and it was observed that the cartilage defects,flatness,and collagen fiber distribution in the degen-erative+vorinostat group were superior to those in the degenerative group.Conclusion Vorinotat inhibits HDAC-2 activity,regulates histone deacetylation,increases the expression of type Ⅱ collagen and proteo-glycans,and promotes bone inflammation injury repair.

VorinostatHistone deacetylase-2Cartilage inflammationType Ⅱ collagenProteoglycans

孙东方、戴磊、靳宜楷、马占华

展开 >

郑州大学第一附属医院骨科,郑州 450052

伏立诺他 组蛋白去乙酰化酶-2 软骨炎症 Ⅱ型胶原 蛋白多糖

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(2)
  • 6